tradingkey.logo
搜索

Embecta Corp

EMBC
添加自选
5.620USD
+0.040+0.72%
收盘 09-24 16:00(美东)
333.43M总市值
2.94市盈率 TTM

关于 Embecta Corp 公司

Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.

Embecta Corp 简介

公司代码EMBC
公司名称Embecta Corp
上市日期Mar 21, 2022
CEOKurdikar (Devdatt)
员工数量1850
证券类型Ordinary Share
年结日Mar 21
公司地址300 Kimball Drive
城市PARSIPPANY
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编07054
电话18624010000
网址https://www.embecta.com/
公司代码EMBC
上市日期Mar 21, 2022
CEOKurdikar (Devdatt)

Embecta Corp公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
321.24K
+9.34%
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
321.24K
+9.34%
Mr. Jacob (Jake) Elguicze
Mr. Jacob (Jake) Elguicze
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
134.14K
+14.91%
Mr. Jacob (Jake) Elguicze
Mr. Jacob (Jake) Elguicze
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
134.14K
+14.91%
Mr. Jeffrey Z. (Jeff) Mann
Mr. Jeffrey Z. (Jeff) Mann
Senior Vice President, General Counsel, Product Development
Senior Vice President, General Counsel, Product Development
115.43K
+17.33%
Mr. Jeffrey Z. (Jeff) Mann
Mr. Jeffrey Z. (Jeff) Mann
Senior Vice President, General Counsel, Product Development
Senior Vice President, General Counsel, Product Development
115.43K
+17.33%
Mr. Robert J. (Bob) Hombach, CPA
Mr. Robert J. (Bob) Hombach, CPA
Independent Director
Independent Director
94.70K
+47.52%
Mr. Robert J. (Bob) Hombach, CPA
Mr. Robert J. (Bob) Hombach, CPA
Independent Director
Independent Director
94.70K
+47.52%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Independent Director
Independent Director
55.24K
+41.35%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Independent Director
Independent Director
55.24K
+41.35%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
321.24K
+9.34%
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
321.24K
+9.34%
Mr. Jacob (Jake) Elguicze
Mr. Jacob (Jake) Elguicze
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
134.14K
+14.91%
Mr. Jacob (Jake) Elguicze
Mr. Jacob (Jake) Elguicze
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
134.14K
+14.91%
Mr. Jeffrey Z. (Jeff) Mann
Mr. Jeffrey Z. (Jeff) Mann
Senior Vice President, General Counsel, Product Development
Senior Vice President, General Counsel, Product Development
115.43K
+17.33%
Mr. Jeffrey Z. (Jeff) Mann
Mr. Jeffrey Z. (Jeff) Mann
Senior Vice President, General Counsel, Product Development
Senior Vice President, General Counsel, Product Development
115.43K
+17.33%

常见问题

Embecta Corp的前五大股东是谁?

Embecta Corp 的前五大股东如下:Mr. Devdatt (Dev) Kurdikar

有多少机构持有Embecta Corp(EMBC)的股份?

截至2026Q1,共有791家机构持有Embecta Corp的股份,合计持有的股份价值约为59.40M,占公司总股份的100.13%。与2025Q4相比,机构持股有所增加,增幅为-4635325.00。

哪个业务部门对Embecta Corp的收入贡献最大?

在2026Q1,Pen Needles业务部门对Embecta Corp的收入贡献最大,创收177.50M,占总收入的65.33%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有